Skip to main content

Table 1 Clinical characteristics of studied patients based on CIN development

From: Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

 

No-CIN (n=346)

CIN (n= 54)

P value

Age (years)

55.80 ± 10.58

64.20 ± 13.16

< 0.001

BMI (kg/m2)

26.45 ± 3.19

28.27 ± 4.09

0.31

Sex

 Male

302 (87.3%)

35 (64.8%)

< 0.001

 Female

44 (12.7%)

19 (35.2%)

Diabetes mellitus

86 (24.9%)

22 (40.7%)

0.01

Hypertension

63 (18.2%)

19 (35.2%)

< 0.001

IHD

31 (9%)

6 (11.1%)

0.83

CVS

39 (2.6%)

0

0.26

Heart rate (beat/min)

79.73 ± 13.74

86.20 ± 15.07

< 0.001

DBP (mmHg)

79.12 ± 12.77

76.85 ± 12.41

0.80

SBP (mmHg)

120.56 ± 12.45

124.07 ± 26.31

0.20

Ejection fraction (%)

48.95 ± 12.57

49.78 ± 11.47

0.65

  1. Data were expressed as frequency (percentage) and mean (SD). P value was significant if < 0.05
  2. CIN contrast-induced nephropathy, IHD ischemic heart disease, CVS cerebrovascular stroke, BMI body mass index